GREENSTONE LLC—your partner for generic medications
Founded in 1993, GREENSTONE is a wholly owned subsidiary of Pfizer Inc, one of the world's largest pharmaceutical companies. We offer a robust product portfolio of generic medications that cover a broad range of therapeutic areas. According to an IMS Health report from January 2014, based on unbranded generics sales, GREENSTONE is a top-10 generics company in the United States.1 Our mission is to leverage our expertise to deliver reliable, quality generic medications and value to our customers.
At GREENSTONE, you will find a team of sales and business professionals who are committed to product quality, supply, and making GREENSTONE an industry generic supplier of choice. Our Business Alliances Team provides extensive industry experience in generic medications to extend the life cycle of your brand.
From executing short-term loss of exclusivity strategies to negotiating the authorized generic marketplace we helped pioneer,2 GREENSTONE can provide critical support to your organization in a wide range of areas, including:
- Financial modeling
- Pricing analytics
- Commercial launch and supply-chain management
- Rebate administration
- Operational services
References: 1. Data on file. U.S. Pharmaceutical
Market: Trends, Issues & Outlook. GREENSTONE LLC, Peapack, NJ; 2014.
2. Data on file. Onboard meeting. GREENSTONE LLC, Peapack, NJ; 2011.